Immunotherapy for metastatic renal cell carcinoma: Treatment with plak cells and low-dose interleukin-2: Treatment with plak cells and low-dose interleukin-2
D. Engelstein, J. Shmueli, O. Kessler, E. Mukamel, B. Nussbaum, H. Hadar, Z. Ossimi, A. Novogrodsky, C. Servadio
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Immunotherapy for metastatic renal cell carcinoma: Treatment with plak cells and low-dose interleukin-2: Treatment with plak cells and low-dose interleukin-2'. Together they form a unique fingerprint.